| Application no. and date | 19816755.3 (espacenet) (Federated) (European Patent Register), 20191212 | | Patent/reg. no. and date | DK/EP 3897844, 20231115 | | Publication date | 20211027 | | Priority no. and date | EP 18214059, 20181219 | | EP pub. no. and date |
EP 3897844 20211027 | | Effective date | | | Applicant/owner | Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280
69120 Heidelberg , DE | | Applicant ref. no. | | | Inventor | Willuda, Jörg, Staerkstr. 47a
16548 Glienicke/Nordbahn, DE,
TRAUTWEIN, Mark, Narzissenweg 4
42489 Wülfrath, DE,
OFFRINGA, Rienk, c/o Deutsches Krebsforschungszentrum Heidelberg
Im Neuenheimer Feld 280
69120 Heidelberg, DE,
BÖHM, Hans-Henning, c/o Deutsches Krebsforschungszentrum Heidelberg
Im Neuenheimer Feld 280
69120 Heidelberg, DE,
BECKHOVE, Philipp, c/o Deutsches Krebsforschungszentrum Heidelberg
Im Neuenheimer Feld 280
69120 Heidelberg, DE | | Representative | | | Opponent | | | IPC Class | A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | PHARMACEUTICAL COMBINATION OF ANTI CEACAM6 AND TIM3 ANTIBODIES | | Int. application no. | EP2019084849 | | Int. publication no. | WO2020126808 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
